8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-1(2H)-isoquinolinone,
duvelisib,
IPI-145,
Duvelisib,
1201438-56-3,
IPI-145,
(S)-3-(1-((9H-Purin-6-yl)amino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one,
INK-1197,
UNII-610V23S0JI,
IPI 145,
INK1197,
IPI145,
610V23S0JI,
INK-1147,
Copiktra,
(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one,
Duvelisib (IPI-145, INK1197),
IPI-145 (INK1197),
Duvelisib [USAN:INN],
1(2H)-Isoquinolinone, 8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-,
1(2H)-Isoquinolinone, 8-chloro-2-phenyl-3-[(1S)-1-(9H-purin-6-ylamino)ethyl]-,
AK145604,
Duvelisib (USAN/INN),
ipi-145-ink1197,
IPI-145 pound>>Duvelisib,
SCHEMBL153543,
GTPL7795,
CHEMBL3039502,
SCHEMBL18343557,
SCHEMBL19670020,
SCHEMBL20580104,
DTXSID80152697,
SYN1175,
CHEBI:131169,
SJVQHLPISAIATJ-ZDUSSCGKSA-N,
AOB87713,
BCP07042,
EX-A1562,
BDBM50193013,
MFCD15144635,
s7028,
ZINC88346058,
AKOS022186370,
Duvelisib (IPI-145 INK1197),
IPI-145, INK 1197, Duvelisib,
CS-0888,
DB11952,
SB16470,
KS-0000062P,
NCGC00351482-01,
AC-30239,
AS-16309,
BC600328,
compound 4904 [Patent US8193182],
HY-17044,
QC-10232,
AB0032504,
AJ-128213,
AX8268013,
ST24036081,
SW219822-1,
X5816,
A12422,
D10555,
W-5592,
(S)-3-(1-(7H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one,
8-Chloro-2-phenyl-3-((1S)-1-(7H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one,
INK-1197|||IPI-145|||8-Chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one,
Duvelisib [USAN],
C22H17ClN6O,
D0RU0O,